(firstQuint)Efficacy and Safety Study of Haporine-S for Treatment of Moderate to Severe Dry Eye Syndromes.

 This study is to compare the efficacy and the safety of topical Haposine-S and Restasis(R) eye drop 0.

05% for the patients with moderate to severe dry eye disease in a multicenter, investigator(assessor) blind, parallel design, non-inferiority phase III trial.

 Primary outcome is the change of corneal staining score(Oxford scheme) at 12 weeks from baseline.

.

 Efficacy and Safety Study of Haporine-S for Treatment of Moderate to Severe Dry Eye Syndromes@highlight

The purpose of this study is to determine efficacy and safety of Haporine-S eye drop for the patients with moderate to severe dry eye disease in a multicenter phase III clinical trial.

